Pfizer, BioNTech not sure on vaccines’ effectiveness on new COVID variant ‘Omicron’
Washington [US]: The pharmaceutical companies Pfizer and BioNTech on Saturday issued a statement stating that they are not sure whether their vaccines would be able
Washington [US]: The pharmaceutical companies Pfizer and BioNTech on Saturday issued a statement stating that they are not sure whether their vaccines would be able
Hyderabad (Telangana) [India]: Hyderabad-based Bharat Biotech on Friday announced that the Lancet peer-review confirmed the efficacy analysis of Bharat Biotech’s Covaxin.As per phase-three clinical trials
Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per cent
Washington [US]: The pharmaceutical companies Pfizer and BioNTech on Saturday issued a statement stating that they are not sure whether their vaccines would be able
Hyderabad (Telangana) [India]: Hyderabad-based Bharat Biotech on Friday announced that the Lancet peer-review confirmed the efficacy analysis of Bharat Biotech’s Covaxin.As per phase-three clinical trials
Hyderabad-based Bharat Biotech on Saturday concluded a final analysis for its vaccine Covaxin efficacy from phase-3 clinical trial claiming it to be 77.8 per cent